Skip to content

Dual Task Performance and Type II Diabetes Mellitus

Investigation of Dual Task Performance of Individuals With Type 2 Diabetes Mellitus

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07107620
Enrollment
141
Registered
2025-08-06
Start date
2022-09-01
Completion date
2023-06-01
Last updated
2025-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dual Task Cost, Type II Diabetes Mellitus

Keywords

Type II Diabetes Mellitus, Dual-task, Cognition

Brief summary

The aim of this study is to compare the dual task performances of individuals with and without type 2 diabetes. Thus, it will be concluded whether having type 2 diabetes affects dual task performance.

Detailed description

In our daily lives, we often have to juggle many tasks simultaneously. Performing two tasks simultaneously is called dual-tasking. The ability to perform two tasks simultaneously is called dual-tasking performance. Dual-tasking performance can decrease in individuals with diabetes due to complications of diabetes. This study compared the dual-tasking performance of individuals with type 2 diabetes and healthy individuals using dual-tasking tests categorized as easy, medium, and difficult.

Interventions

DIAGNOSTIC_TESTone task

Single task tests consist of measuring walking times with normal walking (easy), walking with a 50% reduction in the base of support measured between the medial malleoli (medium difficulty) and tandem walking (difficult) tasks while applying the 10 meter walk test and time up go tests.

DIAGNOSTIC_TESTdual task

Dual task consists of single task plus tests of carrying glasses of water or counting backwards from a given number.

Sponsors

Kahramanmaras Sutcu Imam University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Having been diagnosed with Type II DM (for the Type II diabetes group) * Being 50 years old or older * Being a native Turkish speaker

Exclusion criteria

* Not being able to read and write, * Having communication problems, * Having a score below 24 points on the Standardized Mini-Mental Test, * Having one of the neurological diseases that will affect the study such as Parkinson's, stroke, etc., * Having upper and/or lower extremity surgery in the last year or having a surgical history that will affect walking, * Having retinopathy, foot ulcers, and severe sensory impairment

Design outcomes

Primary

MeasureTime frameDescription
10 meter walk testone dayThe dual task cost was calculated to measure dual task performance by applying the 10-meter walking test as single and dual tasks. This cost will be calculated as follows: (Dual task performance-single task performance)/ single task performance x100
time up go testone dayThe dual task cost was calculated to measure dual task performance by applying the time up go test as single and dual tasks. This cost will be calculated as follows: (Dual task performance-single task performance)/ single task performance x100

Secondary

MeasureTime frameDescription
Stroop testone dayThere are 5 sections in this test. Section 1 includes reading black text, section 2 includes reading colored words related to color names, section 3 includes saying the color of shapes, section 4 includes saying the color of words that are not color names, and section 5 includes saying the color of colored words that are color names. Individuals are asked to read from left to right as fast as possible. The time taken is recorded in seconds.
Dual task surveyone dayIt is a test that questions the difficulties experienced by individuals during dual-task activities in daily life activities. The survey consists of 10 questions. The short duration of the survey is an advantage. The survey, which consists of 5 answers, is scored between 0 and 4. A score of ''4'' indicates that difficulties are experienced very often, ''0'' indicates that there is no difficulty.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026